source
- Astellas reports promising early results for stem cell eye therapy ASP7317 in age-related diseaseAstellas announced data from an early-stage trial of ASP7317, a stem cell-derived therapy aimed at an age-related eye condition. The study showed encouraging signs of efficacy and safety in most p…
- FDA reexamines previously rejected rare cancer therapy amid claims of political interferenceThe FDA has opened a new review of a treatment for a rare form of cancer that it had turned down a few months earlier. The reconsideration arrives as the agency faces fresh allegations that politi…